Preincubating turkey erythrocytes with cholera toxin alters their adenylate cyclase (EC 4.6.1.1) system: basal activity, maximal epinephrine-stimulatable activity, and affinity of the enzyme reaction for epinephrine are all increased. Pretreatment of erythrocytes with choleragenoid prevents these changes. Cholera toxin does not alter [PHlepinephrine uptake by intact erythrocytes. The increase in epinephrine-stimulatable cyclase activity appears to occur at the expense of fluoridestimulatable activity, which is decreased by the toxin. In lysates from both toxin-treated and control cells, maximally stimulating amounts of epinephrine and fluoride, when added in combination, have a nearly additive effect on cyclase activity. These observations suggest that the adenylate cyclase system of the turkey erythrocyte may exist in two interconvertible forms, one that is catecholamine-responsive but fluoride-insensitive, and another that is fluoride-sensitive but not coupled to catecholamine receptors. Cholera toxin appears to stabilize the enzyme in its hormone receptor-coupled form.
Vibrio cholerae enterotoxin (hereafter called "toxin") increases adenylate cyclase (EC 4.6.1.1) activity in the small intestine, thereby stimulating a cAMP-dependent active secretory process (1) . The ability of the toxin to enhance adenylate cyclase activity has been directly or indirectly demonstrated in a variety of tissues. Significant progress has been made in elucidating the structure of cholera toxin (2) (3) (4) (5) (6) and identifying a cell membrane receptor (7) (8) (9) (10) , but the mechanism by which the toxin, once bound to receptor, stimulates adenylate cyclase is not understood (11) .
This communication describes the effects of cholera toxin on the adenylate cyclase system of the turkey erythrocyte. Heretofore this system had been found to exhibit significant enzyme activity only upon addition of 3-adrenergic agonists or fluoride (12) (13) (14) (15) . Cholera toxin, if added to intact erythrocytes, increases adenylate cyclase activity and alters the kinetics of the enzyme's interactions with both epinephrine and fluoride.
MATERIALS AND METHODS
Cholera toxin (molecular weight = 84,000), purified by the method of Finkelstein and LoSpalluto (16) was provided by the SEATO Cholera Research Program and was prepared under contract for the National Institute of Allergy and Infectious Diseases by Dr. R. A. Finkelstein, the University of Texas Southwestern Medical School, Dallas, Texas. Purified choleragenoid (molecular weight = 56,000), prepared by the procedure described by Finkelstein and LoSpalluto (16) Fresh turkey erythrocytes suspended in a modified (1) Krebs-Ringer-bicarbonate solution (KRB) were incubated with toxin for 10 min in the cold (0.1-0.25 ml of packed cells per 1.0 ml of KRB containing 10-to 10-10 M toxin), then washed twice with KRB and incubated with shaking for 3-4 hr at 38°in KRB containing 40 mM D-glucose and 0.2% bovine-serum albumin (standard medium). The suspensions (1 ml of packed cells per 2.5-4 ml of medium) were gassed with 5% CO2 in 02.
cAMP was determined in 0.1-ml aliquots of cell suspensions to which 5 ml of 5% (w/v) Cl3CCOOH containing nCi [3H]-cAMP as recovery marker, was added. The Cl8CCOOH was extracted with diethyl ether and cAMP was assayed in duplicate using the protein kinase binding procedure described by Gilman (17) . Results were expressed as pmoles of cAMP in the cell suspension divided by packed cell volume. The latter was determined by centrifuging at 1200 X g for 10 min. Incubation medium blanks (medium not exposed to cells) gave an apparent cAMP concentration of 0.026 pmoles/,ul (n = 3). After correction for this, cAMP accumulation in the medium during incubation with cells at 38°for 3.5 hr was found to be 0.027 pmoles of cAMP/,ul in control incubations and 0.091 pmoles/,ul in toxin incubations (n = 3 for both).
Comparison with values in Table 1 indicates that more than 85% of total suspension cAMP was intracellular.
To determine adenylate cyclase activity, we apportioned erythrocytes suspended in original incubation medium into individual assay tubes (100 ,ul of packed cells per tube) and centrifuged them for 5 min at 1000 X g. The cells were then hemolyzed by two additions of 0.4 ml of water followed by two additions of 0.4 ml of 50 mM Tris * HCl buffer (pH 7.4) containing 5 mM MgCl2 (Tris-Mg buffer). Between additions samples were shaken and centrifuged for 5 min at 1000 X g and the supernates were discarded; after the final addition, samples were centrifuged for 10 min at 2000 X g. The Epinephrine uptake by intact erythrocytes was measured by adding DL-['H]epinephrine (1 pCi/ml) and various concentrations of L-epinephrine* to erythrocytes suspended in buffer (0.1 ml packed cells/ml) consisting of 150 mM NaCl, 1.25 CaCl2, 1.1 mM MgCl2, and 20 mM Tris HCl, pH 7.4 (Tris-saline). After incubating with ['H]epinephrine, suspensions were centrifuged in the cold for 2-5 min at 2500 X g, the supernates were removed and the cells were resuspended in 10 ml of cold Tris-saline and centrifuged again. Cells were then resuspended in 1.0 ml of Tris-saline to which 0.25 ml of 25% ClaCCOOH was added. After 30 min, each sample was centrifuged and the entire C1,CCOOH supernate was dissolved in 10 ml of Bray's solution (19) 10 min prior to the end of incubation increased cAMP levels 30-fold, the levels again being about 3-fold greater in toxin-treated than in control cells. Fig. 1 shows cAMP responses to epinephrine (50 MM added 10 min before terminating incubation) at various times after exposure to cholera toxin. At each concentration of toxin tested, an increase in cAMP was apparent at 1 hr (earlier samples were not taken) and a peak effect was reached in 3 hr with 10 nM toxin.t As shown in Fig. 2 , pretreatment of cells with toxin decreased the concentration of epinephrine required to achieve a half-maximal effect (hereafter signified by "Ki"). When the data summarized in Fig. 2 Choleragenoid, a biologically inactive protein that is immunologically indistinguishable from cholera toxin (2), has been shown to block binding of the toxin to liver membranes (21) and thymocytes (22) and to block the lipolytic effect of toxin in isolated fat cells (21) . As indicated in Part B of Table 1 , choleragenoid also blocks the effect of toxin on turkey erythrocytes. Since the cells were washed to remove unbound choleragenoid before being exposed to toxin, choleragenoid presumably competes with toxin for the same membrane receptor sites and is not readily dissociated from these sites. Choleragenoid by itself slightly increased the epinephrine-augmented cAMP level.
Adenylate Cyclase Activity in Erythrocyte Lysates. In comparison to control lysates, cyclase activity in lysates of toxintreated cells was greater under "basal" conditions (no epinephrine or fluoride added), was subject to greater enhancement by a maximally stimulating concentration of epinephrine, and had a lower Km for epinephrine (see Table 2 and Fig. 3 ). These effects are qualitatively similar, therefore, to effects of toxin on cAMP levels in intact erythrocytes. Addition of propranolol (10 MAM) to lysates of toxin-treated cells completely inhibited the effect of 10 uM epinephrine, but did not reduce basal cyclase activity. The latter, therefore, does not appear to be due to endogenous catecholamine.
Fluoride-stimulatable cyclase activity was substantially lower in lysates from toxin-treated cells than in control lysates. As indicated in Fig. 4 
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. With both toxin-treated and control lysates, maximally stimulating amounts of epinephrine and fluoride, when added in combination, had a nearly additive effect on cyclase activity (see last 2 rows in Table 2 ). choleragenoid (10 represented epinephrine. DISCUSSION Cholera toxin-treated erythrocytes showed an increase in maximal epinephrine-stimulatable adenylate cyclase activity and a decrease in the apparent Km of the reaction for epinephrine. In principle, the toxin could produce these changes in three ways: (i) by altering epinephrine binding to receptors, (ii) by modifying the membrane constituents (presumably phospholipids) that couple catecholamine receptors to the catalytic component of the enzyme system, or (iii) by modifying the catalytic component itself, rendering it more susceptible to hormonal activation. On the basis of epinephrine binding studies, the first of these possibilities must be considered very unlikely. It would be hazardous at present to attempt to choose between the other two possibilities.
Since cholera toxin reduces the apparent Km of the adenylate cyclase system for epinephrine without appearing to alter the kinetics of epinephrine binding to Levey (24) has shown that myocardial adenylate cyclase loses its hormone responsiveness when it is solubilized, but retains its fluoride sensitivity. Hormone responses can then be restored by adding certain phospholipids to the solubilized enzyme (25) (26) (27) 
